No prior testing?

'Denied a fundamental right'

(NaturalNews) A new study has found that Merck & Co., the maker of the human papillomavirus (HPV) vaccine Gardasil , neglected to examine the drug's effect on the reproductive systems of women.As a result of that neglect, as well as the inherent dangers behind the vaccine, an Australian girl has suffered debilitating consequences, with her ovaries completely destroyed, the websitereported. The which publicized the case of the 16-year-old girl, said the damage occurred three years after she was vaccinated.Thesummarized:"Its occurrence raises important questions about causation, which may signal other systemic concerns. This patient presented with amenorrhoea after identifying a change from her regular cycle to irregular and scant periods following vaccinations against human papillomavirus. She declined the oral contraceptives initially prescribed for amenorrhoea. The diagnostic tasks were to determine the reason for her secondary amenorrhoea and then to investigate for possible causes of the premature ovarian failure identified. Although the cause is unknown in 90% of cases, the remaining chief identifiable causes of this condition were excluded. Premature ovarian failure was then notified as a possible adverse event following this vaccination. The young woman was counselled regarding preservation of bone density, reproductive implications and relevant follow-up. This event could hold potential implications for population health and prompts further inquiry.""Parents should be warned by this example not to allow use of Garadsil in the case of their daughters,"reported.The recent study pointed out that the vaccine has the ability to severely damage the function of ovaries; in the case of the Australian 16-year-old, her destroyed ovaries led to very premature menopause As reported by, Dr. Deirdre Little, the Australian physician who treated the girl and co-authored thereport, provided researchers with solid evidence that Gardasil caused the destruction of the girl's fertility.In addition, she pointed out that Merck has no supporting information regarding the effects of the vaccine on ovaries, which of course suggests that Merck either did no safety testing regarding the vaccine's effects on the female reproductive system, or has hidden the data.What's more, the drug maker was able to get Gardasil approved via the Food and Drug Administration (FDA) despite incomplete fertility testing.A report from Little said that before the Gardasil vaccine the girl in question had normal menstrual cycles, was thoroughly examined and tested, and did not have a family or personal medical history that would explain the premature menopause.The girl was administered the vaccination in the fall of 2008, and by January 2009 her cycle had become irregular. Over the course of two years, her periods became increasingly light and irregular. By 2011, she had ceased having cycles altogether.Asreported further:"Dr. Little carried out numerous tests on the girl, including checking hormone levels and internal organ function, and diagnosed her as having 'premature ovarian failure.' She also found that the girl had no living egg cells."After investigating other possible causes of the girl's premature ovarian failure, Dr. Little was left with the Gardasil vaccination as the only remaining explanation."In the report, entitled, "Premature ovarian failure 3 years after menarche in a 16-year-old girl following human papillomavirus vaccination," Little wrote that Merck had only tested Gardasil's effects on the testes of rats.In contacting the Therapeutic Goods Administration (TGA) of Australia – which is the equivalent of the United States' FDA – for information about the safety testing of Gardasil on ovaries , Little found that the TGA only had records of the tests on rat testes, but none on the effects of the drug on rat ovaries."Gardasil has been controversial from the beginning," noted Steven Mosher of the Population Research Institute."Tens of millions of young girls have received the Gardasil vaccine since its approval by the FDA six years ago. If even a tiny fraction of them have experienced infertility as a result, then these girl children have been denied a very fundamental right, that is, the right to decide how many children they want to have," he told